Omnicell, Inc.
AI verdict & sentimentAI analysisGenerated by AI from underlying data
Today's AI verdict on what's driving $OMCL, plus how loud the X conversation is and which way it's leaning.
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Equipment & Services sits in its cycle right now — and what that implies for $OMCL.
Medical - Equipment & Services
No material change from last week — FDA compounded semaglutide rule clarification and Amazon Pharmacy's GLP-1 entry are resolving in favor of direct-to-patient platforms, lifting the group 3.8% today.
What this means for $OMCL
Neutral — Makes automated pharmacy dispensing cabinets and medication management software for hospital workflow and patient safety; this business's revenue is largely decoupled from the FDA semaglutide clarity and telehealth structural breakout.
Top industry ETF
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
Past earnings
Quarterly trend
Forward consensus
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Float & profile
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
SEC filings
Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.
Recent material filings
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
In themes
Explore the broader themes this ticker is being talked about under.
More in Medical - Equipment & Services
Peers in the same group — one click to compare setups, fundamentals, and chatter.
No standout posts about $OMCL on X in the last 7 days.